Clinical Trial: Oral THC Reduces Nightmare Frequency and Intensity in Patients With Post-Traumatic Stress

"Taken together, our findings demonstrate that dronabinol is effective in reducing PTSD-related nightmares, with an acceptable safety profile," the study's authors concluded.

The post Clinical Trial: Oral THC Reduces Nightmare Frequency and Intensity in Patients With Post-Traumatic Stress appeared first on NORML.